Mereo BioPharma Group PLC (LSE:MPH) - Share price - Overview


Stock Report

Mereo BioPharma Group PLC MPH

Last Price
GBX167.50

Day Change
0.00|0.00%

As of 06/03/2019
10:57:34 GMT | GBX
Minimum 15 Minutes Delay.

Last Close167.50p
Day Range150.82 - 150.82
Mkt Cap119.30Mil
52-Wk Range150.00 - 352.00
Yield %-
ISINGB00BZ4G2K23
Volume600
P/E-3.01
P/S-
P/CF-0.04

Share Price

Total Returns 20/03/2019

 Chg (%)  
More ...
Mereo BioPharma Group PLC1.52 
FTSE 100 TR GBP1.58
 
Financials
201520162017
More ...
Income Statement
Turnover---
Operating Profit--72.36-90.61
Net Profit--28.39-38.80
Reported EPS--63.00-56.00
Balance Sheet
Current Assets13.8560.7863.18
Non Current Assets26.0225.9933.16
Total Assets39.8686.7796.34
Current Liabilities3.983.219.62
Total Liabilities---
Total Equity35.7479.2662.48
Cash Flow
Operating Cash Flow--30.61-37.48
Net Change in Cash-39.07-2.15
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
21/12/2018PurchaseDr. Denise Vera Scots-Knight185.003,0005,550.00
20/12/2018PurchaseDr. Denise Vera Scots-Knight190.003,0005,700.00

Company Profile

Mereo BioPharma Group PLC is a multi-asset biopharmaceutical company. It is focused on the acquisition, development and commercialization of innovative therapeutics to improve outcomes for patients with rare and specialty diseases.

Sector

Biotechnology

Index

Next Event 22/03/2019

Final Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-53.57
Op Mrgn0.00
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorMr. Anders Olof Adolf Ekblom
Non-Executive Director, ChairmanDr. Peter John Fellner
Non-Executive DirectorMr. Paul Frederick Blackburn
Non-Executive DirectorDr. Peter James Jonathan Bains
Non-Executive DirectorMr. Kunal Ashok Kashyap
Executive Director, Chief Financial OfficerMr. Richard Crispin Morgan Jones
Executive Director, Chief Executive OfficerDr. Denise Vera Scots-Knight
General Counsel & Company SecretaryMr. Charles Sermon
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.